McGrigors and Pinsent Masons to Merge
Released: Monday 6th February 2012
Representing the Scottish Life Sciences Industry
McGrigors and Pinsent Masons to Merge
- Angel Biomedical acquires the assets of a biomaterial and collagen manufacturing business
- Intercell announces EUR 25.0 million financing
- McGrigors and Pinsent Masons merge
- The BioMedical Catalyst – Competition Open
- ProStrakan’s Sancuso Approved in Europe
- Angel Biotechnology Holdings and TransGenRx Inc. sign £800K contract
- Omega Diagnostics predicts revenue rise
- Life sciences set to cash in on £180m funding boost
- Board changes at Optos
- Innovation Centres to support business and university collaboration
- MGB BioPharma ECCMID Poster Abstract Presented
- Eden Scott partners with BioCity Scotland
- SLA welcomes the £100m GSK investment in Scotland
- MGB Biopharma awarded TSB Proof of Concept grant
- TSB Funding call for Stratified Medicine – Diagnostics for Adverse or Non-Response
- SLA Chairman joins BioCity Nottingham board
- SLA welcomes Welsh Assembly largesse
- Tissue Solutions Achieve Certification to ISO 9001
- Alba Bioscience Parent Company, Quotient Biodiagnostics, Raises $11.2 Million of Growth Finance
- Angel Biotechnology appoints Dr. Stewart White as Acting CEO
- Roslin Cells To Manufacture iPS Cells For Bipolar Disorder Research
- BioCity Scotland joins forces with Harrison Goddard Foote
- Integrated Magnetic Systems Ltd awarded a SMART R&D grant for “Magnetic Antibodies”
- Warning Label Wins Backing from US Business High Flier
- Boards 'hampered by non-executives'
- SLA members successful in Medical Research Scotland PhD programme
- SLA welcomes the increased investment in life sciences by the Scottish Government
- No Expiry Date on Ingenuity As UWI Technology Claims Major Award
- Sistemic to work with TiGenix on landmark rheumatoid arthritis cell therapy product
- McGrigors and Pinsent Masons to Merge
- Roslin Cellab’s Study Determines BioCision’s CoolCell® Technology to be superior
- Alba Bioscience receives FDA license to sell additional products in the USA
- BioCity Scotland Ltd secures former MSD research site
- Plant closure led to birth of firm with global ambitions - Gael Limited
- Reid plans expansion at Sistemic
- Drs Russell Greig and Alex Chanas join BigDNA Advisory Board
- NuCana BioMed Secures $10.4 Million Series A Financing
- Mather appointed Chairman of Gael Ltd
- Michael Moore - Secretary of State for Scotland Visits Quintiles in Livingston
- The SLA welcomes the New NRS Career Researcher Scheme
- The University of Edinburgh agrees a collaboration agreement with GSK
- Gael uses iPads to keep aircraft safe
- Ferring Pharmaceuticals Acquires Controlled Therapeutics
- TPP Global Development enters into a collaboration agreement with the University of Dundee
- Omega Diagnostics in India move
- Sistemic supports Talent Scotland
- Axis-Shield receives FDA clearance for new anti-CCP assay
- Cell characterisation experts Sistemic join the Alliance for Regenerative Medicine
- Eden Scott injects fresh expertise into Life Sciences team
- SLA Scottish Life Sciences Engagement week
- Scottish healthcare technology collaboration to support personalised treatment of cancer
- Dr John Brown receives CBE and Kevin Moore an OBE in Queen’s Birthday honours
- BIOMEDICAL COMPANIES SET FOR CHARITY BOOST IN SCOTLAND
- Medical testing firm Omega Diagnostics signs US deal
- SLA writes to new Ministers
- SLA appoints David Harrison to the Advisory Board
- Medical Research Scotland announces an innovative change in funding stream
- Sistemic's, SistemRNA platform selected by Redx Pharma for drug development screening
- SLA appoints John A Brown as Director of Policy
- Grant Thornton calls upon the Government to protect R&D tax incentive schemes for all businesses
- AXIS-SHIELD 2010 PRELIMINARY RESULTS
- New funding for telehealthcare
- Sistemic Sales Gain Pace in 2011
- SLA Launches
© Scottish Lifesciences Association 2012
Scottish Lifesciences Association, 29 Drumsheugh Gardens, Edinburgh, EH3 7RN, Scotland
Registered in Scotland - SC390602
Tel: +44 (0) 131 225 4628